This review offers a framework for Medicaid programs to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Association of a Sweetened Beverage Tax and Soda Consumption in High School Students Clinical Practice Guidelines Error in Figure Clinical Practice Guidelines Probiotics, Prebiotics, and Synbiotics for Prevention of Mortality and Morbidity in Preterm Infants Clinical Practice Guidelines Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates Clinical Practice Guidelines JAMA Pediatrics Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.